Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Greffe allogénique de cellules souches hématopoïétiques dans le lymphome primitif du système nerveux central

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Allogeneic Stem Cell Transplant in Primary CNS Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Axicabtagene ciloleucel and lisocabtagene maraleucel as second-line treatment for patients with relapsed or refractory DLBCL - a real-world analysis of the lymphoma working party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Anna Ossami SAIDY

Axicabtagène ciloleucel et lisocabtagène maraleucel en deuxième ligne chez des patients atteints de lymphome diffus à grandes cellules B (LDGCB) en rechute ou réfractaire : analyse en conditions réelles de pratique du Lymphoma Working Party de l’EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Anna Ossami SAIDY

Real World Experience of CAR-T in follicular lymphoma: a Lymphoma Working Party-EBMT study

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Expérience en vie réelle des thérapies CAR-T dans le lymphome folliculaire : étude du Lymphoma Working Party de l’EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Non-interventional registry-based analysis in the use of Brentuximab Vedotin and/or Checkpoint inhibitors as bridge to autologous stem cell transplantation in Hodgkin lymphoma.

Non-interventional Prospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Analyse non interventionnelle issue d’un registre portant sur l’utilisation du brentuximab védotine et/ou des inhibiteurs de points de contrôle immunitaire en stratégie de relais vers l’autogreffe de cellules souches hématopoïétiques dans le lymphome de Hodgkin

Études prospectives non interventionnelles

Maladie de Hodgkin (MH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Autologous, Allogeneic Stem-Cell Transplantation and CART Cell therapy for Transformed Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) to High Grade NHL (HGNHL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Autogreffe, allogreffe de cellules souches et thérapie par cellules CAR-T dans la macroglobulinémie de Waldenström (MW) / le lymphome lymphoplasmocytaire (LPL) transformés en lymphome non hodgkinien agressif (LNH agressif)

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Stem cell transplantation for ALK-pos. and ALK-neg. anaplastic large cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Evgenii SHUMILOV & Dr. Norbert SCHMITZ

Greffe de cellules souches hématopoïétiques dans le lymphome anaplasique à grandes cellules ALK positif et ALK négatif : analyse rétrospective de l’EBMT-Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Evgenii SHUMILOV & Dr. Norbert SCHMITZ